Skip to content
Glaucoma

Wipeout/Snuff-out Phenomenon (After Glaucoma Surgery)

1. What is the wipe-out/snuff-out phenomenon?

Section titled “1. What is the wipe-out/snuff-out phenomenon?”

Wipe-out or snuff-out phenomenon is a rare but serious complication that occurs after glaucoma surgery. It is characterized by idiopathic and irreversible vision loss that occurs early postoperatively.

It has been mainly reported in association with trabeculectomy, but there are also case reports after cataract surgery. The incidence varies from 0.75% to 13.6% in past studies, and recent evidence suggests it is even less frequent.

A prospective study evaluating the outcomes of end-stage glaucoma has provided important insights into visual prognosis after surgery. Most earlier reports were limited to retrospective analyses, and the variability in incidence is largely due to differences in study design.

Of note, the very existence of this phenomenon has long been a subject of debate, and no clear consensus has been reached.

Q How often does wipeout phenomenon occur?
A

Past reports have shown a wide range of 0.75% to 13.6%, but recent prospective studies suggest it is even less frequent. The variability in incidence reflects differences in study design and severity of the target patients.

  • Acute central vision loss: Noticeable decrease in central vision immediately after surgery (often within 1–2 days postoperatively).
  • Rapid visual field loss: The remaining central visual field disappears within a short period.
  • Absence of eye pain or redness: Characteristically, there is no eye pain or redness, which helps differentiate from other postoperative complications.
  • Severe cases may drop to counting fingers or worse: Vision may decrease to counting fingers or light perception level.
  • Markedly low intraocular pressure: Often shows intraocular pressure of 2 mmHg or lower.
  • Loss of central visual field: The central visual field that remained before surgery is lost.
  • Findings of hypotony maculopathy: Markedly low intraocular pressure (4 mmHg or lower) may present with macular folds, dilation and tortuosity of retinal veins, and optic disc edema.
  • Choroidal folds: May appear radially or concentrically around the optic disc.
  • Choroidal detachment: Detachment with choroidal effusion may be observed.

The exact etiology of the wipe-out phenomenon is currently unknown. Several potential mechanisms have been proposed.

Identified causative factors include the following:

  • Severe hypotony: A rapid and excessive postoperative decrease in intraocular pressure causes impaired blood flow to the optic nerve and retina.
  • Suprachoroidal hemorrhage: Bleeding that occurs when deep choroidal vessels rupture during or after surgery.
  • Cataract formation: Decreased vision due to postoperative lens opacification.
  • Cystoid macular edema: Visual impairment due to macular edema.
  • Optic nerve trauma from retrobulbar anesthesia: Direct injury associated with injection of local anesthetic.
  • Severe uveitis: Prolonged postoperative inflammation.
  • Macular fixation splitting: Instability of the fixation point in end-stage glaucoma.

Having a severely constricted visual field (end-stage glaucoma) before surgery is considered the greatest predisposing factor.

The main risk factors are listed below.

ClassificationRisk FactorsDetails
GeneralAdvanced age, systemic diseasesCardiovascular disease, diabetes
PreoperativeEnd-stage glaucomaMD < −20 dB, fixation split
PostoperativeSevere hypotonyIOP ≤ 2 mmHg, choroidal detachment

Risk factors for suprachoroidal hemorrhage include myopia, glaucoma, diabetes, arteriosclerotic vascular disease, hypertension, and prolonged intraoperative hypotonia1).

Risk factors for expulsive hemorrhage include advanced age, glaucoma, high myopia, aphakia, and arteriosclerotic cardiovascular disease, with an incidence of approximately 0.04–0.1% during cataract surgery.

Q Is it better to avoid surgery for end-stage glaucoma?
A

A careful comparison of the benefits and risks of surgery is necessary, and it cannot be said that surgery should always be avoided. It is possible to choose surgical techniques that reduce the risk of wipeout, such as non-penetrating deep sclerectomy (NPDS) or trabeculectomy with mitomycin C (MMC). For details, see the section on standard treatments.

Wipeout phenomenon is a clinical diagnosis. It is diagnosed as vision loss occurring immediately after glaucoma surgery in patients with risk factors for end-stage glaucoma.

It is important to rule out the following diseases.

Differential diagnosisKey differentiating points
Ocular hypotony maculopathyIntraocular pressure ≤4 mmHg
Choroidal detachment/hemorrhageDome-shaped elevation on ultrasound
Macular edemaMacular thickening on OCT
Retinal detachmentFundus/Ultrasound
Optic neuropathyVisual field/OCT

The main examination methods are shown below.

  • Intraocular pressure measurement and visual acuity test: Confirmation of low intraocular pressure and quantification of visual acuity loss.
  • Slit-lamp microscopy and gonioscopy: Evaluation of anterior segment findings.
  • Fundus examination under mydriasis: Evaluation of the optic disc cup-to-disc ratio (C/D ratio).
  • SAP (Humphrey 10-2): Identification of central visual field defects and fixation splitting.
  • OCT: Evaluation of macular thinning, edema, and retinal nerve fiber layer.
  • Ultrasound (B-scan): Evaluation of dome-shaped elevation due to choroidal hemorrhage.
  • UBM / Anterior segment OCT: Observation of cyclodialysis and ciliary body detachment.
  • Fluorescein angiography: Evaluation of hypotony maculopathy. Confirms delayed retinal circulation, linear hypofluorescence in the folds, and fluorescein leakage from the optic disc.

Prevention is the most important measure against the wipe-out phenomenon. The following strategies are recommended.

  • Careful patient selection and meticulous surgical technique: Special caution is required for patients with end-stage glaucoma.
  • Stepwise intraocular pressure reduction: To avoid sudden perfusion changes, lower intraocular pressure gradually before surgery.
  • Use of adjunctive antifibrotic agents (e.g., MMC): Appropriate use helps stabilize postoperative intraocular pressure control.
  • Avoidance of excessive hypotony through perioperative management: Thoroughly manage intraocular pressure in the early postoperative period.

The focus is on postoperative intraocular pressure stabilization and improvement of ocular perfusion.

  • PGA (prostaglandin analogs), beta-blockers, CAI (carbonic anhydrase inhibitors): Use cautiously within a range that does not cause excessive intraocular pressure reduction.
  • Systemic CAI: Used when intraocular pressure is elevated.
  • Steroids: Used to suppress postoperative inflammation and improve perfusion.
  • Pentoxifylline: May be used to improve blood flow to the optic nerve.

NPDS

Non-penetrating deep sclerectomy (NPDS): This surgical technique avoids a sudden drop in intraocular pressure by not penetrating the eye, minimizing the wipe-out risk while achieving intraocular pressure reduction.

Indications: Particularly useful in cases with high risk for penetrating surgery, such as advanced glaucoma.

Trabeculectomy with Mitomycin C

Trabeculectomy with mitomycin C: Trabeculectomy with adjunctive use of mitomycin C (MMC).

Evidence: A prospective analysis reported no evidence of the wipe-out phenomenon. Proper suture management and postoperative intraocular pressure control are important.

Management of Hypotony and Hypotony Maculopathy

Section titled “Management of Hypotony and Hypotony Maculopathy”
  • When the anterior chamber is lost: Immediately inject viscoelastic material to reform the anterior chamber.
  • When complicated by hypotony maculopathy: Perform autologous blood injection into the bleb or transconjunctival resuturing of the scleral flap (10-0 nylon round needle)5)6).
  • Pressure eye patch: May be effective as conservative treatment.
  • For cyclodialysis: Perform laser photocoagulation (spot size 100–200 μm, duration about 0.2 seconds).

Precautions for Use of Antifibrotic Agents

Section titled “Precautions for Use of Antifibrotic Agents”

Antifibrotic agents are associated with increased risks of hypotony, hypotony maculopathy, late bleb leak, and late infection 2). Laser suture lysis or removal of releasable sutures can be used to adjust aqueous outflow in the early postoperative period 2). Transconjunctival needling (with 5-FU/mitomycin C) is considered effective for reactivating a failing bleb 2).

If expulsive hemorrhage occurs during surgery, first close all wounds. Intraoperative blood pressure management and sedation are effective for prevention.

  • First month after surgery: Conduct weekly examinations.
  • For 6 months after surgery: Continue monthly follow-ups.
  • Regular visual field tests and OCT: Perform regularly for early detection of visual function changes.
Q If a wipe-out phenomenon occurs, can vision be restored?
A

Vision loss is generally irreversible, and no established treatment currently exists to restore it. Therefore, preventive management is most important. The risk of onset can be reduced through stepwise intraocular pressure reduction, careful patient selection, and appropriate postoperative management.

Q Why are end-stage glaucoma patients prone to vision loss after surgery?
A

In end-stage glaucoma, long-term elevated intraocular pressure increases the structural vulnerability of the optic nerve. Additionally, impaired blood flow autoregulation heightens sensitivity to intraocular pressure fluctuations, and a rapid postoperative drop in intraocular pressure is thought to easily induce ischemia of the optic disc and retina. For details on the pathogenesis, see the “Pathophysiology” section.

Vulnerability of the Optic Nerve in End-Stage Glaucoma

Section titled “Vulnerability of the Optic Nerve in End-Stage Glaucoma”

In end-stage glaucoma, the optic nerve is severely damaged due to long-term elevated intraocular pressure and progressive loss of retinal ganglion cells. Such an optic nerve is considered particularly vulnerable to changes in ocular perfusion and pressure dynamics. Accumulation of histopathological studies is insufficient, and the pathological basis has not yet been fully defined.

Three Major Factors Involved in Pathogenesis

Section titled “Three Major Factors Involved in Pathogenesis”

Mechanical Factors

Deformation of the lamina cribrosa: A sudden decrease in intraocular pressure causes mechanical deformation of the lamina cribrosa, leading to axonal damage.

Structural vulnerability of the optic nerve: In end-stage glaucoma, the structure of the lamina cribrosa is already weakened and reacts excessively to even slight pressure changes.

Vascular factors

Decreased perfusion pressure: Low intraocular pressure reduces ocular perfusion pressure, leading to ischemia of the optic disc and retina.

Impaired autoregulation of blood flow: Excessive response to intraocular pressure fluctuations leads to microcirculatory collapse. Sudden intraoperative low intraocular pressure may cause optic nerve hemorrhage or microembolic episodes.

Inflammatory and Hemorrhagic Factors

Postoperative inflammation: Inflammatory cytokines exacerbate vascular damage and enhance direct injury to the optic nerve.

Suprachoroidal hemorrhage: Caused by rupture of deep choroidal vessels. The main cause is intraoperative and postoperative hypotony, with expulsive hemorrhage due to rupture of the posterior ciliary artery being the most severe form.

Markedly low intraocular pressure (IOP ≤4 mmHg) causes the posterior segment of the eye to bow forward, leading to the formation of macular folds. Prolonged hypotony can cause these folds to become fixed, resulting in permanent visual impairment. IOP ≤4 mmHg often leads to severe vision loss (≤0.2).

A meta-analysis of trabeculectomy outcomes reported frequencies of shallow anterior chamber 13.6%, hypotony 11.7%, choroidal effusion 8.3%, and endophthalmitis 1.7%3). These complications can serve as a basis for the wipe-out phenomenon.


Prevention Strategies through Surgical Technique Improvements

Section titled “Prevention Strategies through Surgical Technique Improvements”

NPDS has been reported to significantly lower intraocular pressure while minimizing the risk of wipe-out. Since it does not involve perforation, sudden intraocular pressure fluctuations can be avoided, raising expectations for safety in patients with end-stage glaucoma.

In a prospective analysis of trabeculectomy combined with mitomycin C, no evidence of wipeout phenomenon occurring after surgery was observed. Recent evidence suggests that the incidence of wipeout may be much lower than the figures reported in early retrospective studies.

Treatment Research for Hypotony Maculopathy

Section titled “Treatment Research for Hypotony Maculopathy”

Sakamoto et al. (2018) reported that in hypotony maculopathy after trabeculectomy, excessive scleral contraction, rather than choroidal thickening, is the main cause 4). This finding provided a new perspective on the understanding of the pathology and treatment strategy for hypotony maculopathy.

Shirato et al. (2004) reported a transconjunctival scleral flap resuturing technique for hypotony due to overfiltration 5). This procedure, which resutures the scleral flap without incising the conjunctiva, is noted as a minimally invasive and effective treatment.

Eha et al. (2013) reported long-term outcomes of transconjunctival scleral flap resuturing 6). This technique may be a useful option for managing postoperative hypotony.


  1. Olson RJ, Braga-Mele R, Chen SH, et al. Cataract in the Adult Eye Preferred Practice Pattern. Ophthalmology. 2022;129(1):P1-P126.
  2. Gedde SJ, Vinod K, Wright MM, et al. Primary Open-Angle Glaucoma Preferred Practice Pattern. Ophthalmology. 2021;128(1):P71-P150.
  3. Gedde SJ, Schiffman JC, Feuer WJ, et al. Systematic review of trabeculectomy outcomes and associated risk factors. Surv Ophthalmol. 2023.
  4. Sakamoto M, Matsumoto Y, Mori S, et al. Excessive scleral shrinkage, rather than choroidal thickening, is a major contributor to the development of hypotony maculopathy after trabeculectomy. PLoS One. 2018;13:e0191862.
  5. Shirato S, Maruyama K, Haneda M. Resuturing the scleral flap through conjunctiva for treatment of excess filtration. Am J Ophthalmol. 2004;137:173-174.
  6. Eha J, Hoffmann EM, Pfeiffer N. Long-term results after transconjunctival resuturing of the scleral flap in hypotony following trabeculectomy. Am J Ophthalmol. 2013;155:864-869.

Copy the article text and paste it into your preferred AI assistant.